Sign up for free insights newsletter
ANGELALIGN TECHNOLOGY INC

ANGELALIGN TECHNOLOGY INC

AGLFFUnited States

Need professional-grade analysis? Visit stockanalysis.com

$10.18
+0.00%
End of day
Market Cap

$1.56B

P/E Ratio

65.29

Employees

3,542

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino3.663.013.733.47
Calmar6.113.382.843.83
Sharpe1.391.141.321.28
Omega2.282.563.562.91
Martin15.9013.0316.0815.02
Ulcer5.803.922.673.87

ANGELALIGN TECHNOLOGY INC (AGLFF) Price Performance

ANGELALIGN TECHNOLOGY INC (AGLFF) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $10.18.

Over the past year, AGLFF has traded between a low of $7.13 and a high of $10.18. The stock has gained 42.9% over this period. It is currently 42.9% above its 52-week low.

ANGELALIGN TECHNOLOGY INC has a market capitalization of $1.56B, with a price-to-earnings ratio of 65.29.

About ANGELALIGN TECHNOLOGY INC

Angelalign Technology Inc., an investment holding company, researches and designs, manufactures, sells, and markets clear aligner treatment solutions in the People's Republic of China and internationally. The company's products include Angel Aligner Pro and Angel Aligner Select, a custom made removable clear orthodontic aligners that move the patient's teeth into the proper position over time; Angel Aligner KiD, a early orthodontic solution from prevention to treatment; and Angel Aligner Retainer. It also provides orthodontics and cosmetic dentistry services, and other dental services through its dental clinics. In addition, it sells intraoral scanners; and engages in investing activities. Angelalign Technology Inc. was founded in 2003 and is headquartered in Shanghai, China. Angelalign Technology Inc. is a subsidiary of CareCapital Orthotech Limited.

Compare ANGELALIGN TECHNOLOGY INC

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$308.87M
EBITDA
$24.40M
Profit Margin
7.64%
EPS (TTM)
0.14
Book Value
2.78

Technical Indicators

52 Week High
$10.18
52 Week Low
$7.13
50 Day MA
$8.94
200 Day MA
$8.14
Beta
1.29

Valuation

Trailing P/E
65.29
Forward P/E
41.15
Price/Sales
5.05
Price/Book
3.28
Enterprise Value
$1.14B